Virtual training platform for stress management in veterans
Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App
This study is testing a new online training program to help veterans with PTSD manage stress and see if it improves their symptoms and overall mental health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 79 Years |
| Sex | All |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06494319 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility and effectiveness of a virtual Stress Inoculation Training (SIT) platform, which can be accessed asynchronously by US military veterans diagnosed with PTSD. Participants will use a mobile health application to engage with the training and will be assessed for changes in PTSD symptoms and resilience over time. The study employs Linear Mixed Models to analyze the data collected from participants, focusing on their self-paced learning experience. The goal is to determine if this innovative approach can effectively reduce PTSD symptoms and improve mental health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are US military veterans or service members with a diagnosis of PTSD and a history of combat trauma.
Not a fit: Patients with active suicidal ideation or significant psychotic disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide veterans with a convenient and effective tool for managing PTSD symptoms and enhancing resilience.
How similar studies have performed: Other studies have shown promise in using virtual platforms for mental health interventions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * US Military Veterans / Service Members * diagnosis of PTSD as measured by a Posttraumatic Symptom Checklist for DSM-5 (PCL-5) score of \>33 * history of combat trauma and/or military service in an imminent danger pay area * be fluent in English. * be capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol. * have access to a SmartPhone or tablet to utilize the mobile health app and/OR access the virtual classroom. * agree to undergo psychometric testing and participate in ongoing assessments throughout the study duration. * be willing to comply with all study procedures, able to complete all assessments independently, and available for the duration of the study. Exclusion Criteria: * Active suicidal ideation as assessed by the Investigator at screening or as identified during the study. * Clinically significant history of psychotic disorder, bipolar spectrum disorder, or neurodegenerative disease/dementia as assessed by the Investigator. * Active severe substance abuse as assessed by the investigator in accordance with DSM-5 Substance Abuse Disorder criteria, an AUDIT score \> 15, or partial Brief Addiction Monitor (BAM) indicating the presence of illicit substance use other than cannabis (\< 3 times weekly). * They are currently undergoing another form of treatment other than supportive therapy (\> 2 times per month). * Engaged in active trauma-focused therapy including Cognitive Processing Therapy (CPT)Prolonged Exposure (PE), or Eye Movement Desensitization and Reprocessing (EMDR). * Any other condition/situation that the Investigator believes may interfere with participant safety, study conduct, or interpretation of study data.
Where this trial is running
Houston, Texas
- The University of Texas Health Science Center at Houston — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Sarah Jackson, PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Sarah Jackson, PhD
- Email: Sarah.E.Jackson@uth.tmc.edu
- Phone: (281) 825-9923
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.